- Adherence among chronic disease patients can lead to big savings
- Community-based healthcare models can help diabetic patients
- New alliance will crack down on adulterated products touting dietary supplement claims
- Walgreens' Pegus to discuss impact of diabetes management on healthcare costs
- Oramed announces publication in diabetes journal
PITTSBURGH — The Food and Drug Administration has approved a generic diabetes drug made by Mylan, the drug maker said Tuesday.
Mylan announced the approval of acarbose tablets in the 25-mg, 50-mg and 100-mg strengths. The drug is a version of Bayer’s Precose, used with diet and exercise to improve glycemic control in adults with Type 2 diabetes.
The drug had sales of around $23 million during the 12-month period ended in September, according to IMS Health.